Understand the source comparison
Quickcomparison
Dose Range Defensin (HBD-2) 10–100 μg/mL (research) Defensin (HBD-3) 1–50 μg/mL (research) Frequency As needed Administration Topical application (research/wound care) Cycle Length Ongoing/indefinite Onset Speed Rapid (hours to days) Evidence Level Moderate hu
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Dose Range
- Defensin (HBD-2)
- 10–100 μg/mL (research)
- Defensin (HBD-3)
- 1–50 μg/mL (research)
- Frequency
- As needed
- Administration
- Topical application (research/wound care)
- Cycle Length
- Ongoing/indefinite
- Onset Speed
- Rapid (hours to days)
- Evidence Level
- Moderate human trials (Phase 1-2)
- Efficacy